Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Statin Use is Associated with a Significant Reduction in Cholesterol Content of Erythrocyte Membranes. A Novel Pleiotropic Effect
Cardiovascular Drugs and Therapy, 10/21/09
Tziakas DN et al. – The present study showed, that use of statins is associated with a reduction in CEM, an emerging marker of clinical instability and plaque vulnerability in CAD patients. The pleiotropic effects of statins at the cell membrane level represent a promising novel direction for research in CAD.
Dimitrios N. Tziakas, 10/21/09
| We believe that as cholesterol content of erythrocyte membranes is identified as a novel marker for clinical instability in coronary artery disease new diagnostic and therapeutic approaches are emerging. Statins, whose prognostic benefit lies well beyond their lipid lowering effect seem a potent canditate that can modulate cholesterol metabolism at the cell membrane level |
Related Articles
Screening for Subclinical Coronary Artery Disease Measuring Carotid Intima Media Thickness
The American Journal of Cardiology, 11/10/09
Relevance Score: 83%
Prognostic significance of left ventricular mass by magnetic resonance imaging study in patients with known or suspected coronary artery disease
Journal of Hypertension, 10/28/09
Relevance Score: 83%
Prognostic value of myocardial metabolic imaging with BMIPP in the spectrum of coronary artery disease: A systematic review
Journal of Nuclear Cardiology, 10/28/09
Relevance Score: 83%
Coronary Artery Disease in Patients With Peripheral Artery Disease
Heart & Lung; The Journal of Acute and Critical Care, 10/27/09
Relevance Score: 83%
Coronary artery disease threatens millions, but early diagnosis, treatment can reduce risk
Internet Source, 10/06/09
Relevance Score: 83%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)
The American Journal of Cardiology, 12/01/09
Hyperlipidemia in Older Adults
Clinics in Geriatric Medicine, 12/01/09
Life Course Socioeconomic Conditions and Metabolic Syndrome in Adults: The Atherosclerosis Risk in Communities (ARIC) Study
Annals of Epidemiology , 12/01/09
Sponsor
Article Search
Sponsor


See Latest Articles


